Sri Lanka has recorded 91,346 dengue cases and 68 deaths so far this year, while the case fatality rate stands at 0.07%.

According to the National Dengue Control Unit, the highest monthly burden was reported in July with 29,968 cases, followed by June (21,533) and August (6,004).

District‑wise, Gampaha leads with 19,467 cases (21.3%), closely followed by Colombo at 18,133 (19.8%). Other high‑incidence districts include Kalutara (6,626), Kandy (5,021), and Galle (3,678).

By province, the Western Province accounts for more than half of the total caseload with 48,338 cases (53%). The Southern Province reported 11,679 cases, while the Central Province recorded 8,546.

Health authorities note that 119 MOH areas were classified as high‑risk in Week 31, with an average of 1,509 new cases reported daily.

Authorities continue to urge the public to take preventive measures, including eliminating mosquito breeding sites and seeking early medical attention for suspected symptoms. (Newswire)

The post Sri Lanka dengue cases top 91,000 appeared first on Newswire.

Sri Lanka’s dengue death toll has climbed to 68 this year, with health authorities reporting a case fatality rate of 0.075%, according to the latest surveillance data from the National Dengue Control Unit. 

As of midnight on August 12, the total number of dengue cases in 2026 has reached 91,059. 

The highest monthly caseload was recorded in July with 29,971 cases, followed by June (21,533) and May (8,590). August has already seen 5,714 cases reported.

District‑level data show Gampaha leading with 19,406 cases (21.31%), closely followed by Colombo with 18,901 cases (20.76%). Other high‑burden districts include Kandy (8,146), Matara (6,318), and Kalutara (5,998).

By province, the Western Province accounts for more than half of the national total, reporting 48,244 cases (52.98%). The Southern Province follows with 13,146 cases (14.44%), while the Central Province has 10,234 cases (11.24%).

Health officials also flagged 119 high‑risk MOH areas during Week 31 of 2026, with an average of 1,509 new cases per day.

Authorities continue to urge communities to remain vigilant, stressing that Sri Lanka’s industrial and urban zones remain particularly vulnerable to mosquito breeding, and that coordinated prevention measures are critical to curbing the spread. (Newswire)

The post Dengue death toll rises to 68 in Sri Lanka appeared first on Newswire.

Sri Lanka has recorded 90,695 dengue cases so far in 2026, with health authorities warning of sustained high transmission across several districts and provinces. 

According to the National Dengue Control Unit, 5,348 cases were reported in August up to midnight on August 11, following a sharp surge of 29,973 cases in July and 21,533 in June.

The Western Province remains the epicenter, accounting for more than half of all cases (52.9%). Gampaha (19,291 cases) and Colombo (16,909 cases) are the hardest‑hit districts, together contributing nearly 40% of the national total. Other high‑burden districts include Kandy (6,466), Matara (5,990), and Kalutara (5,416).

Southern Province has reported 12,206 cases, while Central Province recorded 7,475. Smaller but notable clusters have emerged in Sabaragamuwa (5,114), North Western (4,050), and Uva (4,137). Northern and Eastern provinces continue to report lower totals, with 1,287 and 2,799 cases respectively.

Health officials confirmed 65 dengue‑related deaths this year, translating to a case fatality rate of 0.07%. The number of high‑risk Medical Officer of Health (MOH) areas stood at 119 during Week 31, with an average of 1,509 new cases reported daily.

Authorities have urged intensified community‑level prevention measures, particularly in urban and semi‑urban areas where mosquito breeding sites are prevalent. (Newswire)

The post Dengue cases in Sri Lanka near 91,000 by mid‑August appeared first on Newswire.

Dengue cases in Sri Lanka have surged past 90,000 this year, with the latest surveillance data showing 90,306 infections reported as of midnight on August 10.

According to the National Dengue Control Unit, July recorded the highest monthly toll with 29,973 cases, followed by June with 21,533. August has already seen 4,959 cases in just 10 days, underscoring the continuing spread of the disease.

District‑wise, Gampaha remains the worst affected with 19,204 cases (21.27%), while Colombo follows closely at 17,965 (19.89%). Other high‑burden districts include Kandy and Kalutara, each reporting 6,971 cases.

Provincial data shows the Western Province accounts for more than half of all infections (52.96%), with 37,169 cases. The Southern Province reported 13,367 cases, while Central and Sabaragamuwa provinces recorded 7,904 and 7,438 respectively.

The report also highlights 119 high‑risk Medical Officer of Health (MOH) areas during Week 31, with an average of 1,509 new cases recorded daily.

So far this year, 65 dengue‑related deaths have been confirmed, with a case fatality rate of 0.07%.

Health authorities continue to urge communities to eliminate mosquito breeding sites and remain vigilant. (Newswire)

The post Sri Lanka dengue cases top 90,000 in 2026 appeared first on Newswire.

Sri Lanka has recorded 89,639 dengue cases so far in 2026, with 65 deaths reported, according to the latest figures from the National Dengue Control Unit. The case fatality rate stands at 0.07 percent.

The highest monthly surge was seen in July, which alone accounted for 29,973 cases, followed by June with 21,533 cases. In August, 4,292 cases have already been reported as of midnight on August 9.

District‑wise, Gampaha leads with 19,067 cases (21.27%), followed by Colombo with 14,967 cases (16.70%) and Kandy with 6,366 cases (7.10%). Other high‑burden districts include Matara (5,735) and Kalutara (4,914).

By province, the Western Province remains the epicenter, accounting for more than half of the national total, 47,448 cases (52.93%). The Southern Province reported 11,761 cases (13.12%), while the Central Province recorded 7,208 cases (8.04%).

Health authorities note that 119 MOH areas were classified as high‑risk in Week 31 of 2026, with an average of 1,509 new cases per day. 

Health authorities continue to urge the public to follow preventive measures and eliminate mosquito breeding sites to curb the spread. (Newswire)

The post Sri Lanka records 89,639 dengue cases, 65 deaths in 2026 appeared first on Newswire.

Sri Lanka has reported 88,088 dengue cases so far this year, with infections surging sharply in June and July, according to official data released as of midnight on August 5.

Monthly figures show a steady rise from 7,866 cases in January to a peak of 29,975 in July, while August has already recorded 2,739 cases in its first week.

The Western Province remains the hardest hit, accounting for more than half of all cases (46,651; 52.9%). Within the province, Gampaha (18,739) and Colombo (17,490) districts top the list. Other high‑burden districts include Kandy (6,195), Matara (5,910), and Kalutara (5,753).

Nationwide, 63 dengue deaths have been reported this year, with a case fatality rate of 0.07%. Health authorities have identified 137 high‑risk MOH areas in Week 30, with an average of 2,027 new cases daily.

Officials continue to urge the public to eliminate mosquito breeding sites and seek immediate medical attention for suspected symptoms, as the active southwest monsoon is expected to worsen conditions conducive to dengue transmission. (Newswire)

The post Sri Lanka records over 88,000 dengue cases in 2026 appeared first on Newswire.

India has donated 500 litres of Technical Malathion to Sri Lanka to bolster the country’s ongoing efforts to combat the dengue outbreak. 

The consignment was formally handed over today by Indian High Commissioner Santosh Jha to Health Minister Nalinda Jayatissa.

According to the Indian HighCommission, the gift, supplied by Indian company UPL Limited, reached Colombo within two weeks of Sri Lanka’s request, underscoring India’s role as a first responder in times of crisis. 

Sri Lanka has recorded around 86,000 dengue cases in 2026, with the Western Province among the worst affected. The Malathion will support large‑scale fogging and spraying operations being carried out by health authorities to contain the spread of the disease.

Speaking at the handover, High Commissioner Jha reaffirmed India’s commitment to supporting Sri Lanka in line with the government’s priorities and praised the Ministry of Health for its cooperation in facilitating the supply.

The initiative, described as another example of the close, people-centric partnership between the two nations, reflects India’s enduring commitment to its Neighbourhood First policy. (Newswire)

The post India gifts 500 litres of Malathion to aid Sri Lanka’s dengue control appeared first on Newswire.

Sri Lanka has recorded 86,947 dengue cases so far in 2026, according to the latest data issued by the National Dengue Control at midnight on August 3.

Authorities confirmed 62 dengue‑related deaths this year, with a case fatality rate of 0.07%, underscoring the severity of the outbreak.

The epidemic peaked in July with 29,975 cases, followed by June with 21,533. August has already logged 1,598 cases in its first days.

District‑wise, Gampaha (18,464 cases, 21.2%) and Colombo (17,187 cases, 19.8%) remain the hardest hit, together accounting for over 40 percent of the national total. Other high‑burden districts include Kandy (6,082), Matara (5,874), and Kalutara (5,678).

By province, the Western Province alone contributes 52.9% of cases (45,976), underscoring its status as the epicenter of the epidemic. The Southern (13,029) and Central (7,623) provinces follow.

Surveillance also flagged 137 high‑risk MOH areas in Week 30, with an average of 2,027 new cases per day. 

Health officials continue to urge vigilance, especially in densely populated urban zones, as the monsoon season sustains breeding conditions for mosquitoes. (Newswire)

The post Sri Lanka dengue cases near 87,000 as Western Province bears brunt appeared first on Newswire.

A pregnant mother and her seven‑month‑old unborn child have died from dengue, underscoring the severity of the outbreak that continues to grip Sri Lanka.

The woman, a resident of Wadduwa, was admitted to hospital with severe illness and later transferred to the Intensive Care Unit. Despite doctors’ efforts, both mother and child could not be saved. 

The tragedy comes as Sri Lanka has recorded 86,386 dengue cases so far in 2026, with 62 deaths and a case fatality rate of 0.07%, according to official latest data. July alone saw nearly 30,000 infections, while August has already reported over 1,000 cases.

The Western Province remains the hardest hit, accounting for more than half of all cases (45,675), led by Gampaha (18,321) and Colombo (17,101). The Southern Province has reported 12,969 cases, while the Central Province has recorded 7,567.

Health officials have urged communities to strengthen mosquito control and remain vigilant as the monsoon rains continue. (Newswire)

The post Pregnant woman and unborn child latest victims of dengue outbreak appeared first on Newswire.

Sri Lanka’s dengue death toll has climbed to 62 this year, underscoring the severity of the outbreak that has already infected 84,724 people nationwide.

July alone saw 29,350 new cases, the highest monthly figure so far in 2026, following 21,533 cases in June. 

The surge highlights a sharp escalation compared to earlier months, when infections ranged between 5,000 and 8,000.

The Western Province remains the hardest hit, accounting for 44,829 cases, more than half the national total. 

Gampaha (17,971) and Colombo (16,814) districts continue to lead the outbreak, while Kandy (5,782) and Kalutara (5,626) also report significant numbers. 

Southern Province follows with 17,378 cases, while Sabaragamuwa (9,110) and Central Province (7,136) show rising trends.

Smaller districts such as Kilinochchi (53) and Mullaitivu (43) have reported comparatively fewer cases, but health officials warn that transmission risks remain across the island.

Latest data from the National Dengue Control Unit further identifies 175 high‑risk MOH areas during Week 29, with an average of 2,391 new cases daily. 

The case fatality rate stands at 0.07%, reflecting the continuing challenge of controlling the spread despite intensified public health measures. Authorities urge communities to step up mosquito‑control efforts and remain vigilant. (Newswire)

The post Dengue death toll rises to 62 as cases top 84,000 appeared first on Newswire.

Dengue has claimed 61 lives in Sri Lanka this year, with the total number of reported cases climbing to 84,091 by midnight on July 29, according to the National Dengue Control Unit.

July alone recorded 28,717 infections, making it the worst month so far, followed by June with 21,533 cases. Earlier months saw lower but steady numbers: May (8,590), April (5,651), March (6,013), February (5,721), and January (7,866).

District‑wise, the highest burden was reported from Gampaha (17,850 cases, 21.23%) and Colombo (16,716 cases, 19.88%). Other heavily affected districts include Kandy (5,793), Matara (5,730), and Kalutara (5,493).

By province, the Western Province accounted for more than half of all infections (44,552 cases, 52.98%), followed by the Southern Province with 18,127 cases (21.55%). Central (6,674), Sabaragamuwa (6,898), North Western (4,463), North Central (1,548), and Northern (1,446) provinces reported smaller shares.

Health authorities noted 175 high‑risk Medical Officer of Health (MOH) areas during Week 29, with an average of 2,391 new cases reported daily. The case fatality rate remains at 0.07%.

Communities are urged to eliminate mosquito breeding sites and strengthen preventive measures as the outbreak intensifies across the island. (Newswire)

The post Dengue cases in Sri Lanka rise past 84,000; death toll at 61 appeared first on Newswire.

Sri Lanka has reported 82,838 dengue cases so far this year, with infections surging in July to 27,464 cases, the highest monthly tally.

Health authorities confirmed 61 dengue‑related deaths to date, with a case fatality rate of 0.07%. 

The latest data from the National Dengue Control Unit flags 175 high‑risk MOH areas in Week 29, with an average of 2,391 new cases daily.

The Western Province remains the epicenter, accounting for more than half of all cases (43,884). Within the province, Gampaha (17,600 cases) and Colombo (16,457 cases) are the hardest‑hit districts. Other high‑burden areas include Kandy (4,847), Matara (4,728), and Kalutara (4,598).

Southern and Sabaragamuwa provinces also face significant outbreaks, recording 12,197 and 9,112 cases respectively. Smaller districts such as Mannar (89) and Mullaitivu (49) reported comparatively low numbers.

Health officials urge communities to eliminate mosquito breeding sites and seek prompt medical care for fever. (Newswire)

The post Sri Lanka records over 82,000 dengue cases in 2026, Western Province worst hit appeared first on Newswire.

Sri Lanka has recorded 82,011 dengue cases so far in 2026, with July alone accounting for 26,636 infections, according to the National Dengue Control Unit.

According to the latest data released at midnight on July 26, the Western Province remains the hardest hit, reporting 43,388 cases, more than half of the national total (52.9%). Within the province, Gampaha (17,395 cases) and Colombo (16,294 cases) are the highest‑burden districts. The Southern Province follows with 12,419 cases, while Central (7,068) and Sabaragamuwa (6,793) also report significant numbers.

Fatalities stand at 61 deaths, with a case fatality rate of 0.07%. Health authorities have identified 175 high‑risk MOH areas during Week 29, with an average of 2,391 new cases reported daily.

District‑level data show Matara (5,639) and Kandy (5,634) nearly equal in case counts, while Kalutara (5,355), Ratnapura (4,553), and Galle (4,543) also remain hotspots. In contrast, northern districts such as Kilinochchi (49) and Mullaitivu (49) report the lowest figures.

Health officials warn that the continuing rise in cases highlights the urgent need for intensified vector control measures, community awareness, and early medical intervention to prevent further spread. (Newswire)

The post Dengue cases in Sri Lanka surge past 82,000 by July appeared first on Newswire.

A special clinic to treat dengue patients will be opened at the National Ayurveda Hospital in Borella from Friday, July 31, amid the current spread of dengue in Sri Lanka.

Hospital Director Dr. Parakrama Hemachandra said patients wishing to receive treatment under the Ayurvedic medical system can visit the hospital for treatment through the specialised clinic.

Meanwhile, Consultant Physician Dr. Saminda Ariyaratne warned dengue patients against using home remedies or medicines that have not been prescribed by a qualified Western or Ayurvedic medical practitioner.

He particularly cautioned against remedies such as papaya leaf juice, saying some dengue patients had developed serious conditions and complications after consuming such remedies.

Dr. Ariyaratne also urged the public not to prepare or consume remedies based on messages circulating on social media.

He stressed that dengue patients should only take medicines prescribed by qualified Western or Ayurvedic medical practitioners. (Newswire)

The post Special dengue clinic to open at National Ayurveda Hospital amid warning against home remedies appeared first on Newswire.

Sri Lanka has recorded a sharp rise in dengue cases this year, with official surveillance data showing 80,114 infections as of July 23, 2026 midnight.

Health officials confirmed 59 dengue‑related deaths this year, with a case fatality rate of 0.07%. As of Week 29, there are 175 high‑risk MOH areas, with an average of 2,391 new cases reported daily. 

The outbreak has intensified in recent months, with 24,739 cases reported in July alone, making it the worst month so far. June also saw a high number of cases at 21,534, while earlier months recorded comparatively lower figures.

The Western Province remains the most affected, accounting for more than half of all cases nationwide. Gampaha has reported 16,950 infections, while Colombo has recorded 16,091, together making up over 40% of the national total. Other districts with significant case numbers include Matara (5,534), Kandy (4,827), Kalutara (4,545), and Ratnapura (4,428). The Colombo Municipal Council area itself has reported over 3,200 cases.

Across provinces, the Southern Province has reported 12,143 cases, Central Province 6,686, and Sabaragamuwa 6,607. Smaller but notable outbreaks have been recorded in North Western (3,844), Eastern (3,148), Uva (2,154), North Central (1,264), and Northern (1,173).

Authorities have urged residents in high‑risk districts to step up mosquito control measures and seek immediate medical care for suspected symptoms, warning that the outbreak could worsen if preventive action is not strictly followed. (Newswire)

The post Dengue cases in Sri Lanka surge past 80,000 appeared first on Newswire.

Sri Lanka has recorded 79,016 dengue cases so far this year, with July alone accounting for 23,641 cases, according to the latest data of the National Dengue Control Unit, released at midnight on July 22.

The figures show a sharp rise compared to earlier months, with 21,534 cases in June, 8,590 in May, and fewer than 6,000 cases each in March and April. January reported 7,866 cases, while February saw 5,721.

District‑wise, Gampaha leads with 16,676 cases (21.1%), followed by Colombo at 15,748 (19.9%). Other high‑burden districts include Matara (5,495), Kandy (5,318), Kalutara (5,190), Ratnapura (4,444), and Galle (4,391). The Colombo Municipal Council (CMC) area alone reported 3,184 cases.

Provincial data highlights the Western Province as the epicenter, contributing 41,753 cases (52.8%) of the national total. The Southern Province follows with 12,041 cases (15.2%), while Central (6,699) and Sabaragamuwa (6,599) provinces each account for over 8% of the caseload.

So far in 2026, a total of 57 dengue‑related deaths have been reported, with a case fatality rate of 0.07%. Authorities have identified 175 high‑risk MOH areas during Week 29, with an average of 2,391 new cases per day.

Health officials warn that the continuing surge underscores the urgent need for intensified vector control measures and public cooperation to curb the spread of dengue across the island. (Newswire)

The post Dengue cases in Sri Lanka surge past 79,000 in 2026 appeared first on Newswire.

A four‑year‑old girl from Dickwella has died of dengue hemorrhagic fever while receiving treatment at the Pediatric Intensive Care Unit of Galle National Hospital.

The child was first admitted to Dickwella District Hospital with severe fever, later transferred to Matara General Hospital, and subsequently moved to Galle National Hospital for intensive care. 

Despite treatment, she succumbed to complications on Monday (20), with the sudden death inquiry and post‑mortem examination confirming dengue hemorrhagic fever. 

The death comes as Sri Lanka has recorded 78,125 dengue cases so far in 2026, with 56 fatalities and a case fatality rate of 0.07%.

July alone has seen 22,749 infections, following 21,355 in June, underscoring sustained high transmission.

The Western Province remains the hardest hit, accounting for 41,236 cases (52.78%), led by Gampaha and Colombo. 

The Southern Province has reported 11,950 cases, with Matara and Galle among the highest‑burden districts.

Authorities have identified 162 high‑risk MOH areas in Week 28, with an average of 2,652 new cases reported daily.

Public health officials continue to urge vigilance, noting that the seasonal peak has intensified earlier than expected, placing pressure on hospitals across the island. (Newswire)

The post Four‑year‑old child succumbs amid Dengue spike appeared first on Newswire.

Sri Lanka’s dengue crisis deepened this week with the official death toll rising to 56 fatalities in 2026, underscoring the severity of the outbreak that has already infected 77,028 people nationwide. 

Health authorities warn that the case fatality rate, though relatively low at 0.07%, reflects the growing strain on hospitals as infections continue to climb.

The latest surveillance data shows July leading with 21,650 cases, narrowly surpassing June’s 21,537. 

Together, these two months account for more than half of the year’s total infections, highlighting the seasonal spike during the monsoon period.

Regionally, the Western Province remains the epicenter, recording 40,573 cases (52.67%), with Gampaha (16,164) and Colombo (15,341) districts hardest hit. 

The Southern Province follows with 11,867 cases, while Central and Sabaragamuwa provinces each report over 6,000 infections. Smaller districts such as Mullaitivu and Kilinochchi, though less affected, still reflect the nationwide spread of the disease.

Health authorities have identified 162 high‑risk MOH areas in Week 28, with an average of 2,652 new cases reported daily at midnight counts. 

Public health officials continue to urge communities to eliminate mosquito breeding sites and seek immediate medical attention for suspected symptoms. (Newswire)

The post Death toll from dengue climbs to 56 as cases surge past 77,000 appeared first on Newswire.

The Drug Controller General of India (DCGI) has approved Takeda Biopharmaceuticals India’s dengue vaccine, QDENGA, for the prevention of dengue in individuals aged 4–60 years under the New Drugs and Clinical Trials (NDCT) Rules, 2019.

QDENGA is the first dengue vaccine approved in India and can be used in individuals regardless of previous dengue exposure, without the need for pre-vaccination testing.

This approval marks an important step in strengthening dengue prevention efforts in India, where the disease remains a significant public health challenge.

Dengue is a mosquito-borne viral disease that poses a significant global public health threat, with prevalence in over 125 countries.

India accounts for nearly one-third of the global dengue burden. In 2025, reported cases exceeded 113,000, but modelling analyses suggest the dengue burden in India appears to be higher than reported, likely representing tens of millions of infections each year. 

QDENGA is a tetravalent, live-attenuated vaccine designed to provide protection against all four dengue virus serotypes. The vaccine is administered subcutaneously as a 0.5 mL two-dose regimen, with doses given three months apart.

QDENGA is recommended by the WHO for use in dengue-endemic settings and supports its introduction into public immunisation programmes in areas with high transmission, without the need for pre-vaccination screening. The vaccine has also received WHO pre-qualification, confirming it meets global standards for quality, safety, and efficacy, and enabling eligibility for procurement through international agencies such as UNICEF and PAHO to support wider access.

QDENGA has been approved in 43 countries across Asia, Latin America, and Europe, including India, with more than 32 million doses distributed globally through public and private programmes. It is included in Brazil’s National Immunisation Programme and is available through public programmes in Argentina, Colombia, and Indonesia.

Dr. Mahender Nayak, Head of Intercontinental Markets, said, “The latest seven-year data for QDENGA show continued protection against dengue infection and hospitalisation across all four serotypes, an important milestone for communities and health systems. Since its launch in 2022, QDENGA has been approved in 43 countries, with more than 32 million doses distributed globally. This approval marks an important step forward in strengthening dengue prevention in India.”

Millions of Indians remain at risk each year due to widespread endemicity, rapid urbanisation, and climate-related factors that drive mosquito proliferation. This has made dengue a year-round public health threat, with seasonal surges continuing to strain healthcare systems.

Dengue is also complex to manage, with no specific treatment. It can rapidly progress to severe, life-threatening complications requiring hospitalisation and intensive care.

Peter Streibl, General Manager, Southeast Asia and India Cluster, said, “Dengue is a shared regional challenge that requires collaboration across borders and sectors. Takeda is committed to working with governments, public health authorities, healthcare professionals, and partners across South and Southeast Asia not only to support access to QDENGA, where approved and recommended, but also to strengthen broader dengue prevention efforts, including surveillance, awareness, vector control, and community engagement.”

Dr. Goh Choo Beng, Medical Affairs Head, Southeast Asia & India Cluster, added that India carries a substantial dengue burden, and all four dengue virus serotypes have been documented as co-circulating in several regions. QDENGA is designed to protect against all four serotypes, regardless of prior exposure. 

QDENGA APPROVAL BASED ON CLINICAL TRIALS

The approval in India is based on results from Takeda’s global clinical development program, involving 19 Phase 1, 2, and 3 clinical trials with over 28,000 participants in both endemic and non-endemic regions. This included the pivotal Phase III TIDES (DEN-301) trial, which evaluated the vaccine in over 20,000 participants across eight countries over an extended period to assess both the long-term safety and efficacy of QDENGA.

At 12 months following the second dose, the study met its primary endpoint, demonstrating an overall vaccine efficacy of 80.2% against virologically confirmed dengue (VCD). At 18 months, the study also demonstrated 90.4% efficacy against dengue-related hospitalisation, meeting a key secondary endpoint of the study.

After 4.5 years, two doses of QDENGA provided 84.1% vaccine efficacy in preventing dengue-related hospitalisations. Notably, the vaccine has also shown sustained safety and efficacy for up to seven years across all four dengue virus serotypes.

This approval is also supported by data from a Phase III clinical trial (DEN-302) conducted in Indian participants, which evaluated the safety and immunogenicity of the vaccine in individuals aged 4–60 years. The study demonstrated that QDENGA was well tolerated, safe, and immunogenic in healthy adults, adolescents, and children.

These clinical outcomes are further supported by real-world evidence generation and ongoing pharma-covigilance to deepen understanding of the vaccine’s safety and impact.

Following approval by the DCGI, Takeda will continue to collaborate with Indian regulatory authorities, public health stakeholders, and healthcare providers to support the planning, delivery, and availability of QDENGA in India. (India Today)

The post India approves first dengue vaccine QDENGA for people aged 4-60 years appeared first on Newswire.

Sri Lanka’s dengue outbreak has escalated sharply, with the National Dengue Control Unit (NDCU) reporting 76,044 cases nationwide as of midnight on 19 July 2026.

Daily surveillance shows 2,652 new patients were recorded on July 19 alone, while 162 Medical Officer of Health (MOH) divisions remain classified as high‑risk zones.

Monthly figures highlight the surge: May recorded 8,590 cases, June 21,537, and July has already reached 20,666 cases within just 19 days. 

Earlier months saw lower totals, with January at 7,866, February 5,721, March 6,013, and April 5,651.

The NDCU confirmed 53 dengue‑related deaths this year, with a case fatality rate of 0.07%.

At provincial level, the Western Province remains the epicenter, accounting for 52.61% of all infections (31,220 cases). The Southern Province follows with 11,645 cases (19.62%), while the Central Province has 5,241 cases (8.67%).

District‑wise, Gampaha (15,910 cases) and Colombo (15,310 cases) are the hardest hit, together representing over 40% of the national burden. Other high‑impact districts include Matara (5,319 cases), Kalutara (4,960), Ratnapura (4,260), and Galle (4,206).

Health authorities continue to urge the public to keep surroundings clean and to seek immediate medical treatment if fever symptoms appear, stressing that unchecked mosquito breeding remains the primary driver of the surge. (Newswire)

The post Dengue cases in Sri Lanka surpass 76,000 by mid‑July appeared first on Newswire.